ClearPoint Neuro, Inc. Announces First-in-Human Cases of

$ 12.00

4.7 (391) In stock

SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing

ClearPoint Neuro, Inc.

UNILAD, Human Brain Connected Wirelessly To Computer For First Time Ever, Media

form10-k_005.jpg

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency - 新浪香港

Pharmaceutics, Free Full-Text

Brain Monitoring Market Size, Share, Growth Trends, Forecast 2024-2033

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

ClearPoint Neuro (Nasdaq:CLPT) - Stock Price, News & Analysis - Simply Wall St

ClearPoint Neuro and Higgs Boson Health Announce Collaboration — Duke OTC

ClearPoint Neuro (Nasdaq:CLPT) - Stock Price, News & Analysis

ClearPoint Neuro: The New Neurosurgical Platform Of Choice (NASDAQ:CLPT)